These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38081327)

  • 1. Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics.
    Vieira DFB; Bandeira DM; da Silva MAN; de Almeida ALT; Araújo M; Machado AB; Tort LFL; Nacife VP; Siqueira MM; Motta FC; Pauvolid-Corrêa A; Barth OM
    Braz J Infect Dis; 2024; 28(1):103706. PubMed ID: 38081327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models.
    Mautner L; Hoyos M; Dangel A; Berger C; Ehrhardt A; Baiker A
    Virol J; 2022 Apr; 19(1):76. PubMed ID: 35473640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages.
    Prince T; Dong X; Penrice-Randal R; Randle N; Hartley C; Goldswain H; Jones B; Semple MG; Baillie JK; Openshaw PJM; Turtle L; Hughes GL; Anderson ER; Patterson EI; Druce J; Screaton G; Carroll MW; Stewart JP; Hiscox JA
    mSphere; 2022 Jun; 7(3):e0091321. PubMed ID: 35491827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis.
    Mastrorosa I; Cozzi-Lepri A; Colavita F; Lalle E; Mazzotta V; Cimaglia C; Paulicelli J; Matusali G; Fabeni L; Carletti F; Rosati S; Vita S; Giannico G; Piselli P; Biliotti E; Moghazi SA; Mosti S; Girardi E; Nicastri E; Garbuglia AR; Maggi F; Vaia F; Antinori A
    J Clin Virol; 2022 Dec; 157():105299. PubMed ID: 36183546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
    Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
    mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ultrastructural and genomic study on the SARS-CoV-2 variant B.1.210 circulating during the first wave of COVID-19 pandemic in India.
    Kumar N; Santhoshkumar R; Prasad P; George AK; Aiyar J; Joshi S; Narayanappa G; Desai AS; Ravi V; Venkataswamy MM
    Indian J Med Microbiol; 2023; 41():45-52. PubMed ID: 36870749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
    Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
    J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
    Barreto-Vieira DF; da Silva MAN; Garcia CC; Miranda MD; Matos ADR; Caetano BC; Resende PC; Motta FC; Siqueira MM; Girard-Dias W; Archanjo BS; Barth OM
    Mem Inst Oswaldo Cruz; 2021; 116():e200443. PubMed ID: 33566951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds.
    Lee BU
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency.
    Mariotti S; Capocefalo A; Chiantore MV; Iacobino A; Teloni R; De Angelis ML; Gallinaro A; Pirillo MF; Borghi M; Canitano A; Michelini Z; Baggieri M; Marchi A; Bucci P; McKay PF; Acchioni C; Sandini S; Sgarbanti M; Tosini F; Di Virgilio A; Venturi G; Marino F; Esposito V; Di Bonito P; Magurano F; Cara A; Negri D; Nisini R
    Front Immunol; 2021; 12():750386. PubMed ID: 34764961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.
    Despres HW; Mills MG; Shirley DJ; Schmidt MM; Huang ML; Roychoudhury P; Jerome KR; Greninger AL; Bruce EA
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35058348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants.
    Alonzi T; Aiello A; Repele F; Falasca L; Francalancia M; Garbuglia AR; Delogu G; Nicastri E; Piacentini M; Goletti D
    Cell Death Discov; 2022 Jun; 8(1):288. PubMed ID: 35705564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier
    Lebourgeois S; Chenane HR; Houhou-Fidouh N; Menidjel R; Ferré VM; Collin G; Benmalek N; Coppée R; Larrouy L; Yazdanpanah Y; Timsit JF; Charpentier C; Descamps D; Visseaux B
    Front Cell Infect Microbiol; 2021; 11():792202. PubMed ID: 34976868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
    Luo CH; Morris CP; Sachithanandham J; Amadi A; Gaston D; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH
    medRxiv; 2021 Aug; ():. PubMed ID: 34462756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System.
    Barreto-Vieira DF; da Silva MAN; de Almeida ALT; Rasinhas ADC; Monteiro ME; Miranda MD; Motta FC; Siqueira MM; Girard-Dias W; Archanjo BS; Bozza PT; L Souza TM; Gomes Dias SS; Soares VC; Barth OM
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates.
    Feng XL; Yu D; Zhang M; Li X; Zou QC; Ma W; Han JB; Xu L; Yang C; Qu W; Deng ZH; Long J; Long Y; Li M; Yao YG; Dong XQ; Zeng J; Li MH
    Virol Sin; 2022 Dec; 37(6):804-812. PubMed ID: 36167254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.